Audiological Devices Market

Table of Content

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

5. Market Outlook

    5.1. Key Mergers & Acquisitions

    5.2. Technological Advancements

    5.3. Regulatory Scenario of Audiological Devices

6. Global Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Market Value Forecast, by Product, 2022–2032

        6.3.1. Hearing Aids

            6.3.1.1. In-the-ear Hearing Aids (ITE)

            6.3.1.2. Receiver-in-the-ear hearing Aids (RITE)

            6.3.1.3. Behind-the-ear Hearing Aids (BTE)

            6.3.1.4. Canal hearing aids (CHA)

        6.3.2. Cochlear Implants

        6.3.3. Bone-anchored Hearing Aids

        6.3.4. Diagnostic Devices

            6.3.4.1. Audiometers

            6.3.4.2. Octoscopes

            6.3.4.3. Tympanometers

    6.4. Global Market Attractiveness, by Product

7. Global Market Analysis and Forecast, by Disease

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Market Value Forecast, by Disease, 2022–2032

        7.3.1. Otosclerosis

        7.3.2. Meniere's Disease

        7.3.3. Acoustic Tumors

        7.3.4. Otitis Media

        7.3.5. Others

    7.4. Global Market Attractiveness, by Disease

8. Global Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Market Value Forecast, by End-user, 2022–2032

        8.3.1. Hospitals

        8.3.2. Ambulatory Surgical Centers

        8.3.3. Clinics

    8.4. Global Market Attractiveness, by End-user

9. Global Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Global Market Attractiveness, by Country/Region

10. North America Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Market Value Forecast, by Product, 2022–2032

        10.2.1. Hearing Aids

            10.2.1.1. In-the-ear Hearing Aids (ITE)

            10.2.1.2. Receiver-in-the-ear hearing Aids (RITE)

            10.2.1.3. Behind-the-ear Hearing Aids (BTE)

            10.2.1.4. Canal hearing aids (CHA)

        10.2.2. Cochlear Implants

        10.2.3. Bone-anchored Hearing Aids

        10.2.4. Diagnostic Devices

            10.2.4.1. Audiometers

            10.2.4.2. Octoscopes

            10.2.4.3. Tympanometers

    10.3. North America Market Value Forecast, by Disease, 2022–2032

        10.3.1. Otosclerosis

        10.3.2. Meniere's Disease

        10.3.3. Acoustic Tumors

        10.3.4. Otitis Media

        10.3.5. Others

    10.4. North America Market Value Forecast, by End-user, 2022–2032

        10.4.1. Hospitals

        10.4.2. Ambulatory Surgical Centers

        10.4.3. Clinics

    10.5. North America Market Value Forecast, by Country, 2022–2032

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Disease

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Market Value Forecast, by Product, 2022–2032

        11.2.1. Hearing Aids

            11.2.1.1. In-the-ear Hearing Aids (ITE)

            11.2.1.2. Receiver-in-the-ear hearing Aids (RITE)

            11.2.1.3. Behind-the-ear Hearing Aids (BTE)

            11.2.1.4. Canal hearing aids (CHA)

        11.2.2. Cochlear Implants

        11.2.3. Bone-anchored Hearing Aids

        11.2.4. Diagnostic Devices

            11.2.4.1. Audiometers

            11.2.4.2. Octoscopes

            11.2.4.3. Tympanometers

    11.3. Europe Market Value Forecast, by Disease, 2022–2032

        11.3.1. Otosclerosis

        11.3.2. Meniere's Disease

        11.3.3. Acoustic Tumors

        11.3.4. Otitis Media

        11.3.5. Others

    11.4. Europe Market Value Forecast, by End-user, 2022–2032

        11.4.1. Hospitals

        11.4.2. Ambulatory Surgical Centers

        11.4.3. Clinics

    11.5. Europe Market Value Forecast, by Country/Sub-region, 2022–2032

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Russia

        11.5.7. Rest of Europe

    11.6. Europe Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Disease

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Europe Market Value Forecast, by Product, 2022–2032

        12.2.1. Hearing Aids

            12.2.1.1. In-the-ear Hearing Aids (ITE)

            12.2.1.2. Receiver-in-the-ear hearing Aids (RITE)

            12.2.1.3. Behind-the-ear Hearing Aids (BTE)

            12.2.1.4. Canal hearing aids (CHA)

        12.2.2. Cochlear Implants

        12.2.3. Bone-anchored Hearing Aids

        12.2.4. Diagnostic Devices

            12.2.4.1. Audiometers

            12.2.4.2. Octoscopes

            12.2.4.3. Tympanometers

    12.3. Europe Market Value Forecast, by Disease, 2022–2032

        12.3.1. Otosclerosis

        12.3.2. Meniere's Disease

        12.3.3. Acoustic Tumors

        12.3.4. Otitis Media

        12.3.5. Others

    12.4. Europe Market Value Forecast, by End-user, 2022–2032

        12.4.1. Hospitals

        12.4.2. Ambulatory Surgical Centers

        12.4.3. Clinics

    12.5. Europe Market Value Forecast, by Country/Sub-region, 2022–2032

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Europe Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Disease

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Market Value Forecast, by Product, 2022–2032

        13.2.1. Hearing Aids

            13.2.1.1. In-the-ear Hearing Aids (ITE)

            13.2.1.2. Receiver-in-the-ear hearing Aids (RITE)

            13.2.1.3. Behind-the-ear Hearing Aids (BTE)

            13.2.1.4. Canal hearing aids (CHA)

        13.2.2. Cochlear Implants

        13.2.3. Bone-anchored Hearing Aids

        13.2.4. Diagnostic Devices

            13.2.4.1. Audiometers

            13.2.4.2. Octoscopes

            13.2.4.3. Tympanometers

    13.3. Market Value Forecast, by Disease, 2022–2032

        13.3.1. Otosclerosis

        13.3.2. Meniere's Disease

        13.3.3. Acoustic Tumors

        13.3.4. Otitis Media

        13.3.5. Others

    13.4. Latin America Market Value Forecast, by End-user, 2022–2032

        13.4.1. Hospitals

        13.4.2. Ambulatory Surgical Centers

        13.4.3. Clinics

    13.5. Latin America Market Value Forecast, by Country, 2022–2032

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Disease

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Market Value Forecast, by Product, 2022–2032

        14.2.1. Hearing Aids

            14.2.1.1. In-the-ear Hearing Aids (ITE)

            14.2.1.2. Receiver-in-the-ear hearing Aids (RITE)

            14.2.1.3. Behind-the-ear Hearing Aids (BTE)

            14.2.1.4. Canal hearing aids (CHA)

        14.2.2. Cochlear Implants

        14.2.3. Bone-anchored Hearing Aids

        14.2.4. Diagnostic Devices

            14.2.4.1. Audiometers

            14.2.4.2. Octoscopes

            14.2.4.3. Tympanometers

    14.3. Middle East & Africa Market Value Forecast, by Disease, 2022–2032

        14.3.1. Otosclerosis

        14.3.2. Meniere's Disease

        14.3.3. Acoustic Tumors

        14.3.4. Otitis Media

        14.3.5. Others

    14.4. Middle East & Africa Market Value Forecast, by End-user, 2022–2032

        14.4.1. Hospitals

        14.4.2. Ambulatory Surgical Centers

        14.4.3. Clinics

    14.5. Middle East & Africa Market Value Forecast, by Country/Sub-region, 2022–2032

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Israel

        14.5.4. Rest of Middle East & Africa

    14.6. Middle East & Africa Market Attractiveness Analysis

        14.6.1. By Product

        14.6.2. By Disease

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Company Profiles

        15.1.1. William Demant Holding A/S

            15.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.1.2. Company Financials

            15.1.1.3. Growth Strategies

            15.1.1.4. SWOT Analysis

        15.1.2. GN Store Nord A/S

            15.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.2.2. Company Financials

            15.1.2.3. Growth Strategies

            15.1.2.4. SWOT Analysis

        15.1.3. Sonova

            15.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.3.2. Company Financials

            15.1.3.3. Growth Strategies

            15.1.3.4. SWOT Analysis

        15.1.4. WIDEX A/S

            15.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.4.2. Company Financials

            15.1.4.3. Growth Strategies

            15.1.4.4. SWOT Analysis

        15.1.5. Sivantos Pte. Ltd.

            15.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.5.2. Company Financials

            15.1.5.3. Growth Strategies

            15.1.5.4. SWOT Analysis

        15.1.6. Medtronic

            15.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.6.2. Company Financials

            15.1.6.3. Growth Strategies

            15.1.6.4. SWOT Analysis

        15.1.7. Starkey

            15.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.7.2. Company Financials

            15.1.7.3. Growth Strategies

            15.1.7.4. SWOT Analysis

        15.1.8. Audina Hearing Instruments, Inc.

            15.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.8.2. Company Financials

            15.1.8.3. Growth Strategies

            15.1.8.4. SWOT Analysis

        15.1.9. AUDITDATA

            15.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.9.2. Company Financials

            15.1.9.3. Growth Strategies

            15.1.9.4. SWOT Analysis

        15.1.10. Nurotron Biotechnology Co. Ltd.

            15.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.1.10.2. Company Financials

            15.1.10.3. Growth Strategies

            15.1.10.4. SWOT Analysis

List Of Table

Table 01: Global Market Value (US$ Mn) Forecast, by Product, 2022–2032

Table 02: Global Market Value (US$ Mn) Forecast, by Hearing Aids, 2022–2032

Table 03: Global Market Value (US$ Mn) Forecast, by Diagnostic Devices, 2022-2032

Table 04: Global Market Value (US$ Mn) Forecast, by Disease, 2022–2032

Table 05: Global Market Value (US$ Mn) Forecast, by End-user, 2022–2032

Table 06: Global Value (US$ Mn) Forecast, by Region, 2022–2032

Table 07: North America Market Value (US$ Mn) Forecast, by Country, 2022–2032

Table 08: North America Market Value (US$ Mn) Forecast, by Product, 2022–2032

Table 09: North America Market Value (US$ Mn) Forecast, by Hearing Aids, 2022–2032

Table 10: North America Market Value (US$ Mn) Forecast, by Diagnostic Devices, 2022–2032

Table 11: North America Market Value (US$ Mn) Forecast, by Disease, 2022–2032

Table 12: North America Market Value (US$ Mn) Forecast, by End-user, 2022–2032

Table 13: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2032

Table 14: Europe Market Value (US$ Mn) Forecast, by Product, 2022–2032

Table 15: Europe Market Value (US$ Mn) Forecast, by Hearing Aids, 2022–2032

Table 16: Europe Market Value (US$ Mn) Forecast, by Diagnostic Devices, 2022–2032

Table 17: Europe Market Value (US$ Mn) Forecast, by Disease, 2022–2032

Table 18: Europe Market Value (US$ Mn) Forecast, by End-user, 2022–2032

Table 19: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2032

Table 20: Asia Pacific Market Value (US$ Mn) Forecast, by Product, 2022–2032

Table 21: Asia Pacific Market Value (US$ Mn) Forecast, by Hearing Aids, 2022–2032

Table 22: Asia Pacific Market Value (US$ Mn) Forecast, by Diagnostic Devices, 2022–2032

Table 23: Asia Pacific Market Value (US$ Mn) Forecast, by Disease, 2022–2032

Table 24: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2022–2032

Table 25: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2032

Table 26: Latin America Market Value (US$ Mn) Forecast, by Product, 2022–2032

Table 27: Latin America Market Value (US$ Mn) Forecast, by Hearing Aids, 2022–2032

Table 28: Latin America Market Value (US$ Mn) Forecast, by Diagnostic Devices, 2022–2032

Table 29: Latin America Market Value (US$ Mn) Forecast, by Disease, 2022- 2032

Table 30: Latin America Market Value (US$ Mn) Forecast, by End-user, 2022–2032

Table 31: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2032

Table 32: Middle East & Africa Market Value (US$ Mn) Forecast, by Product, 2022-2032

Table 33: Middle East & Africa Market Value (US$ Mn) Forecast, by Hearing Aids, 2022–2032

Table 34: Middle East & Africa Market Value (US$ Mn) Forecast, by Diagnostic Devices, 2022–2032

Table 35: Middle East & Africa Market Value (US$ Mn) Forecast, by Disease, 2022–2032

Table 36: Middle East & Africa Market Value (US$ Mn) Forecast, by End-user, 2022–2032

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Share Specifics with Me

List Of Figures

Figure 01: Global Market Size (US$ Mn) and Distribution, by Region, 2022 and 2032

Figure 02: Global Market Revenue (US$ Mn), by Product, 2022

Figure 03: Global Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2032

Figure 04: Global Market Value (US$ Mn) Forecast, 2022–2032

Figure 05: Global Market Value Share (%), by Product, 2022 and 2032

Figure 06: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hearing Aids, 2022–2032

Figure 07: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cochlear Implants, 2022–2032

Figure 08: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Bone-anchored Hearing Aids, 2022–2032

Figure 09: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diagnostic Devices, 2022–2032

Figure 10: Global Market Attractiveness Analysis, by Product, 2022–2032

Figure 11: Global Market Value Share (%), by Disease, 2022 and 2032

Figure 12: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Otosclerosis, 2022–2032

Figure 13: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Meniere's Disease, 2022–2032

Figure 14: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Acoustic Tumors, 2022–2032

Figure 15: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Otitis Media, 2022–2032

Figure 16: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2022–2032

Figure 17: Global Market Attractiveness Analysis, by Disease, 2022–2032

Figure 18: Global Market Value Share, by End-user, 2022 and 2032

Figure 19: Global Market Attractiveness, by End-user, 2022–2032

Figure 20: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2022–2032

Figure 21: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgical Centers, 2022–2032

Figure 22: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinics, 2022–2032

Figure 23: Global Market Value Share, by Region, 2022 and 2032

Figure 24: Global Market Attractiveness, by Region, 2022–2032

Figure 25: North America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 26: North America Market Value Share (%), by Country, 2022 and 2032

Figure 27: North America Market Attractiveness, by Country, 2022–2032

Figure 28: North America Market Value Share, by Product, 2022 and 2032

Figure 29: North America Market Attractiveness, by Product, 2022–2032

Figure 30: North America Market Value Share Analysis, by Disease, 2022 and 2032

Figure 31: North America Market Attractiveness, by Disease, 2022–2032

Figure 32: North America Market Value Share Analysis, by End-user, 2022 and 2032

Figure 33: North America Market Attractiveness, by End-user, 2022–2032

Figure 34: Europe Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 35: Europe Market Value Share (%), by Country/Sub-region, 2022 and 2032

Figure 36: Europe Market Attractiveness, by Country/Sub-region, 2022–2032

Figure 37: Europe Market Value Share, by Product, 2022 and 2032

Figure 38: Europe Market Attractiveness, by Product, 2022–2032

Figure 39: Europe Market Value Share Analysis, by Disease, 2022 and 2032

Figure 40: Europe Market Attractiveness, by Disease, 2022–2032

Figure 41: Europe Market Value Share Analysis, by End-user, 2022 and 2032

Figure 42: Europe Market Attractiveness, by End-user, 2022–2032

Figure 43: Asia Pacific Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 44: Asia Pacific Market Value Share, by Country/Sub-region, 2022 and 2032

Figure 45: Asia Pacific Market Attractiveness, by Country/Sub-region, 2022–2032

Figure 46: Asia Pacific Market Value Share, by Product, 2022 and 2032

Figure 47: Asia Pacific Market Attractiveness, by Product, 2022–2032

Figure 48: Asia Pacific Market Value Share Analysis, by Disease, 2022 and 2032

Figure 49: Asia Pacific Market Attractiveness, by Disease, 2022–2032

Figure 50: Asia Pacific Market Value Share Analysis, by End-user, 2022 and 2032

Figure 51: Asia Pacific Market Attractiveness, by End-user, 2022–2032

Figure 52: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 53: Latin America Market Value Share, by Country/Sub-region, 2022 and 2032

Figure 54: Latin America Market Attractiveness, by Country/Sub-region, 2022–2032

Figure 55: Latin America Market Value Share, by Product, 2022 and 2032

Figure 56: Latin America Market Attractiveness, by Product, 2022–2032

Figure 57: Latin America Market Value Share Analysis, by Disease, 2022 and 2032

Figure 58: Latin America Market Attractiveness, by Disease, 2022–2032

Figure 59: Latin America Market Value Share Analysis, by End-user, 2022 and 2032

Figure 60: Latin America Market Attractiveness, by End-user, 2022–2032

Figure 61: Middle East & Africa Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 62: Middle East & Africa Market Value Share, by Country/Sub-region, 2022 and 2032

Figure 63: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2022–2032

Figure 64: Middle East & Africa Market Value Share, by Product, 2022 and 2032

Figure 65: Middle East & Africa Market Attractiveness, by Product, 2022–2032

Figure 66: Middle East & Africa Market Value Share Analysis, by Disease, 2022 and 2032

Figure 67: Middle East & Africa Market Attractiveness, by Disease, 2022–2032

Figure 68: Middle East & Africa Market Value Share Analysis, by End-user, 2022 and 2032

Figure 69: Middle East & Africa Market Attractiveness, by End-user, 2022–2032

Figure 70: William Demant Holding A/S Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2021

Figure 71: William Demant Holding A/S Breakdown of Net Sales (%), by Region/Country, 2022

Figure 72: William Demant Holding A/S Breakdown of Net Sales (%), by Product Segment, 2022

Figure 73: William Demant Holding A/S R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2021

Figure 74: GN Store Nord A/S Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2021

Figure 75: GN Store Nord A/S Breakdown of Net Sales (%), by Product Segment, 2022

Figure 76: GN Store Nord A/S Breakdown of Net Sales (%) of GN Hearing Segment, by Region/Country, 2022

Figure 77: Sonova Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2021

Figure 78: Sonova Breakdown of Net Sales (%), by Region/Country, 2022

Figure 79: Sonova Breakdown of Net Sales (%), by Product Segment, 2022

Figure 80: Sonova R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2022–2032

Figure 81: WIDEX A/S Revenue (US$ Mn) and Y-o-Y Growth (%), 2016/17–2017/22

Figure 82: WIDEX A/S Breakdown of Net Sales (%), by Region/Country, 2017/22

Figure 83: Sonova Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2021

Figure 84: Medtronic Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2021

Figure 85: Medtronic Breakdown of Net Sales (%), by Region/Country/geography, 2022

Figure 86: Medtronic Breakdown of Net Sales (%), by Business Segment, 2022

Figure 87: Medtronic R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2021